DalsnaFinance › Analyst accuracy › All targets
Every price target we have verified from published news, newest first: 30 targets from BTIG. Each one shows the article it came from and links to its full entry, and is judged on the close on the date it comes due. “At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target.
Showing targets from BTIG only. All targets BTIG’s record →
BTIG raised its price target to $30.00, maintaining a Buy rating
Analysts from BTIG responded by raising their price target for Haemonetics to $142, maintaining a Buy rating
They currently have a $140.00 target price on the retailer's stock.
BTIG cuts EnerSys stock price target to $250 on revenue miss
Investing.com - BTIG raised its price target on Liquidia Technologies (NASDAQ:LQDA) to $87 from $70
BTIG raised its price target on Solventum (NYSE:SOLV) shares to $100 from $95 while maintaining a Buy rating on Thursday.
BTIG maintained a Buy rating and $220 price target on Texas Roadhouse
BTIG raised its price target on Northwest Natural Gas stock (NYSE:NWN) to $59 from $56 while maintaining a Buy rating.
This guidance led BTIG to lower its price target for Datadog to $260, while maintaining a Buy rating.
BTIG raised its price target on Flywire (NASDAQ:FLYW) to $22 from $20 while maintaining a Buy rating on the shares.
BTIG raised its price target on ONE Gas Inc. (NYSE:OGS) shares to $95 from $89 while maintaining a Buy rating on the stock.
BTIG raised its price target on Tempus AI Inc (NASDAQ:TEM) shares to $100 from $80
BTIG lowered its price target on Bright Minds Biosciences Inc. to $37 from $147 while maintaining a Buy rating.
BTIG lowered its price target on Carvana to $82 from $87 while maintaining a Buy rating
BTIG lowered its price target on Fortinet (NASDAQ:FTNT) to $186 from $203 while maintaining a Buy rating following the company's third-quarter results.
BTIG responded to these developments by lowering its price target for Abbott from $134 to $125, while maintaining a Buy rating.
BTIG reiterated its Buy rating and $2.00 price target on Hyperfine
BTIG reiterated a Buy rating and $2,150 price target on MercadoLibre shares ahead of the company's third-quarter earnings report scheduled for November 4.
raising the price target to $315 while maintaining a Buy rating on the stock.
BTIG reiterates Buy on Starbucks stock, $115 target maintained
BTIG maintained its Buy rating for Levi Strauss, citing diversified growth, and set a price target of $27.00.
Investing.com - BTIG reiterated a Buy rating and $100.00 price target on Uber Inc. (NYSE:UBER) following the company’s announcement of two acquisition deals.
BTIG reiterated a Buy rating and $89.00 price target on Vaxcyte
BTIG reiterated a Buy rating and $18.00 price target on Verastem (NASDAQ:VSTM) shares ahead of an upcoming data presentation.
BTIG reiterated a Buy rating and $5.00 price target on Gain Therapeutics
BTIG raised its price target on Medtronic, Inc. (NYSE:MDT) to $100 from $91 while maintaining a Buy rating
BTIG raised its price target on DexCom stock to $90 from $80 while maintaining a Buy rating following the company's second-quarter earnings report.
BTIG lowered its price target on Boston Scientific Corp. (NYSE:BSX) to $60 from $65 while maintaining a Buy rating on the stock.
MCD Maintained by BTIG -- Price Target Lowered to $350
ABT Maintained with Price Target Raised to $134 by BTIG
Retracted targets, ones we found we had misreported, are not listed here and count toward nothing; each firm's row on the analyst accuracy page lists its own under "Retracted". These are facts about what each firm published, not recommendations from Dalsna Finance.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.